Infrared Thermography to Evaluate the Effect of Paravertebral Block

January 8, 2021 updated by: Wei Mei, Huazhong University of Science and Technology

Changes of Skin Temperature for Evaluation of Paravertebral Block: A Prospective Observational Study Using Infrared Thermography

The aim of this prospective observational study was to evaluate the changes of skin temperature after the paravertebral block measured by infrared thermography.

Study Overview

Status

Completed

Conditions

Detailed Description

Methods: Patients scheduled for elective surgery with paravertebral block will receive infrared thermography measures 5 min before the block and continous to 20 min after the block. The sensitivity, specificity of infrared thermography as diagnostic methods will be determined by receiver operator characteristic analysis.

Study Type

Observational

Enrollment (Actual)

61

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430030
        • Tongji Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients scheduled for elective surgery with planned paravertebral block for multimodel analgesia.

Description

Inclusion Criteria:

  • With informed consent
  • American Society of Anesthesiologists physical status Ⅰ-Ⅱ
  • Undergo elective surgery with planned paravertebral block

Exclusion Criteria:

  • Refusal to participate in the study
  • pre-existing infection at the block site
  • younger than 18-yr-old
  • BMI>35
  • significant thoracic kyphoscoliosis
  • Those who had taken vasodilatory drugs before surgery
  • history of previous thoracic or breast surgery
  • Preoperative analgesic medications
  • Any contraindications to peripheral nerve block such as coagulation abnormalities, allergy to local anaesthetics, peripheral neuropathy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Successful Paravertebral block
Pinprick test was evaluated at 20 min after Paravertebral block. Pinprick sensation was assessed using a 22-gauge short bevel needle from T2 to T10 at midclavicular line bilaterally . Pinprick response was recorded quantitatively as 1 (sensation) or 0 (no sensation/numb). Successful block was defined as the pinprick score was 0 at 20 min after block. Otherwise, it was defined as a failed block.
Paravertebral block is performed at T4 and T5 level under realtime ultrasound guidenance with 10ml of 0.5% ropivacaine for each block, respectively.
Failed Paravertebral block
Pinprick test was evaluated at 20 min after Paravertebral block. Pinprick sensation was assessed using a 22-gauge short bevel needle from T2 to T10 at midclavicular line bilaterally . Pinprick response was recorded quantitatively as 1 (sensation) or 0 (no sensation/numb). Successful block was defined as the pinprick score was 0 at 20 min after block. Otherwise, it was defined as a failed block.
Paravertebral block is performed at T4 and T5 level under realtime ultrasound guidenance with 10ml of 0.5% ropivacaine for each block, respectively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of skin temperature
Time Frame: From baseline up to 20 minutes after block
Changes of skin temperature determined by infrared thermography
From baseline up to 20 minutes after block

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Noinvasive blood pressure
Time Frame: From baseline up to 20 minutes after block
Vital signs
From baseline up to 20 minutes after block
Heart rate
Time Frame: From baseline up to 20 minutes after block
Vital signs
From baseline up to 20 minutes after block
SPO2
Time Frame: From baseline up to 20 minutes after block
vital signs
From baseline up to 20 minutes after block
Sensory block level
Time Frame: From baseline up to 20 minutes after block
Sensory block level determined by pinprick.
From baseline up to 20 minutes after block

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wei Mei, Huazhong University of Science and Technology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

August 30, 2020

Study Completion (Actual)

October 31, 2020

Study Registration Dates

First Submitted

August 6, 2019

First Submitted That Met QC Criteria

September 3, 2019

First Posted (Actual)

September 6, 2019

Study Record Updates

Last Update Posted (Actual)

January 12, 2021

Last Update Submitted That Met QC Criteria

January 8, 2021

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • TJ-IRB20190424

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

For patient's privacy

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Paravertebral Block

Clinical Trials on Paravertebral block at T4 and T5 level

Subscribe